DJIA 17,191.37 -195.84 -1.13%
NASDAQ 4,637.99 -43.50 -0.93%
S&P 500 2,002.16 -27.39 -1.35%
market minute promo


company name or ticker

Cepheid Developing A Rapid Diagnostic Test For Multidrug-Resistant Superbugs

US Stock Futures Edge Lower Ahead Of Consumer Spending Report

Qiagen's therascreen KRAS Gets FDA Nod - Analyst Blog

Qiagen's therascreen KRAS Gets FDA Nod - Analyst Blog

Amgen's Vectibix Label Expanded - Analyst Blog

Is Now the Right Time for This Small-Cap Dividend Stock?

Dividends are a great way to boost your portfolio's performance over the long run. Here is the lowdown on a little-known health-care stock that offers a healthy 4% dividend and is trading close to its 52-week low.

UPDATE: HSBC Upgrades Qiagen N.V. to Neutral

Benzinga's Top Upgrades

Qiagen NV's (QGEN) CEO Peer Schatz on Q1 2014 Results - Earnings Call Transcript

QGEN Crosses Above Key Moving Average Level

Top 4 NASDAQ Stocks In The Research Services Industry With The Highest Revenue

See More Articles...